계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Proof Diagnostics
company
About
Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $45M
- Industries
- Apps,Health Care,Mobile Apps,Product Management
- Founded date
- Jan 1, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$45M
Proof Diagnostics has raised a total of
$45M
in funding over 2 rounds. Their latest funding was raised on
Apr 7, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 7, 2022 | Series A | $45M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Proof Diagnostics is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
